Application of zoledronic acid in the treatment of senile unstable femoral intertrochanteric fractures with anatomical locking plate
10.3969/j.issn.1006-5725.2015.17.037
- VernacularTitle:唑来膦酸在老年不稳定型股骨粗隆间骨折解剖锁定钢板内固定术后的应用
- Author:
Jin SUN
;
Pei LIU
;
Naxin FU
;
Fei LIU
;
Hui HUANG
;
Peng DAI
;
Chunling TAN
- Publication Type:Journal Article
- Keywords:
Anatomical locking plate;
Elderly;
Zoledronic acid;
Unstable femoral intertrochanteric fracture
- From:
The Journal of Practical Medicine
2015;(17):2880-2883
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the efficacy of zoledronic acid in the treatment of senile unstable femoral intertrochanteric fractures with anatomical locking plate. Methods 67 patients were randomly divided into two groups. Five days after the operation, group A received one intravenous injection of 5 mg zoledronic acid, while patients in group B did not receive the injection. The two groups were compared in terms of hospitalization time, complications, limb weight-bearing time, fracture healing time, hip function score after operation, preoperative and postoperative serum calcium and serum ALP, bone mineral density of proximal femur before operation and 1 year after operation. Results There were no statistically significant differences between the two groups in age, type of fracture, hospital stay, partial weight-bearing time, fracture healing time, hip function at 1 month and 1 year after operation, preoperative bone mineral density and blood calcium. But the differences were statistically different in hip function at 3 months after operation , averaged bone mineral density of proximal femur and serum ALP 1 year after operation. Moreover, 5 patients in group A developed muscle pain or fever after intravenous injection of zoledronic acid. Conclusion The locking plate combined with zoledronic acid injection in treatment of elderly patients with unstable femoral intertrochanteric fracture could inhibit bone loss, increase bone mineral density, and accelerate limb function recovery after operation. On the other hand, Zoledronic acid has a high incidence of adverse reaction.
